Cargando…

Analysis of Usage Data from a Self-Guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Controlled Trial

This study examined user engagement with ZeroPhobia, a self-guided app-based virtual reality (VR) Cognitive Behavior Therapy for acrophobia symptoms using cardboard VR viewers. Dutch acrophobic adults (n = 96) completed assessments at baseline and immediately following treatment. Primary outcome mea...

Descripción completa

Detalles Bibliográficos
Autores principales: Donker, Tara, van Klaveren, Chris, Cornelisz, Ilja, Kok, Robin N., van Gelder, Jean-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357041/
https://www.ncbi.nlm.nih.gov/pubmed/32466528
http://dx.doi.org/10.3390/jcm9061614
_version_ 1783558621647339520
author Donker, Tara
van Klaveren, Chris
Cornelisz, Ilja
Kok, Robin N.
van Gelder, Jean-Louis
author_facet Donker, Tara
van Klaveren, Chris
Cornelisz, Ilja
Kok, Robin N.
van Gelder, Jean-Louis
author_sort Donker, Tara
collection PubMed
description This study examined user engagement with ZeroPhobia, a self-guided app-based virtual reality (VR) Cognitive Behavior Therapy for acrophobia symptoms using cardboard VR viewers. Dutch acrophobic adults (n = 96) completed assessments at baseline and immediately following treatment. Primary outcome measures were the Acrophobia Questionnaire (AQ) and the Igroup Presence Questionnaire (IPQ). Usage data consisted of number of VR sessions practiced, practice time, and fear ratings directly after practicing. Results show that of the 66 participants who played at least one level, the majority continued to finish all levels, spending on average 24.4 min in VR. Self-reported fear consistently decreased between the start and finish of levels. Post-test AQ scores depended quadratically on time spent in VR. Higher pre-test AQ scores were significantly associated with subjective anxiety after the first level and a reduction of post-test AQ scores, but not with number of sessions, suggesting it might be more beneficial to play one level for a longer time period instead of practicing many VR levels. Results also show an optimum exposure level at which increasing practice time does not result in increased benefit. Self-guided VR acrophobia treatment is effective and leads to consistent reductions in self-reported anxiety both between levels and after treatment. Most participants progressed effectively to the highest self-exposure level, despite the absence of a therapist.
format Online
Article
Text
id pubmed-7357041
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73570412020-07-23 Analysis of Usage Data from a Self-Guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Controlled Trial Donker, Tara van Klaveren, Chris Cornelisz, Ilja Kok, Robin N. van Gelder, Jean-Louis J Clin Med Article This study examined user engagement with ZeroPhobia, a self-guided app-based virtual reality (VR) Cognitive Behavior Therapy for acrophobia symptoms using cardboard VR viewers. Dutch acrophobic adults (n = 96) completed assessments at baseline and immediately following treatment. Primary outcome measures were the Acrophobia Questionnaire (AQ) and the Igroup Presence Questionnaire (IPQ). Usage data consisted of number of VR sessions practiced, practice time, and fear ratings directly after practicing. Results show that of the 66 participants who played at least one level, the majority continued to finish all levels, spending on average 24.4 min in VR. Self-reported fear consistently decreased between the start and finish of levels. Post-test AQ scores depended quadratically on time spent in VR. Higher pre-test AQ scores were significantly associated with subjective anxiety after the first level and a reduction of post-test AQ scores, but not with number of sessions, suggesting it might be more beneficial to play one level for a longer time period instead of practicing many VR levels. Results also show an optimum exposure level at which increasing practice time does not result in increased benefit. Self-guided VR acrophobia treatment is effective and leads to consistent reductions in self-reported anxiety both between levels and after treatment. Most participants progressed effectively to the highest self-exposure level, despite the absence of a therapist. MDPI 2020-05-26 /pmc/articles/PMC7357041/ /pubmed/32466528 http://dx.doi.org/10.3390/jcm9061614 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Donker, Tara
van Klaveren, Chris
Cornelisz, Ilja
Kok, Robin N.
van Gelder, Jean-Louis
Analysis of Usage Data from a Self-Guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Controlled Trial
title Analysis of Usage Data from a Self-Guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Controlled Trial
title_full Analysis of Usage Data from a Self-Guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Controlled Trial
title_fullStr Analysis of Usage Data from a Self-Guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Controlled Trial
title_full_unstemmed Analysis of Usage Data from a Self-Guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Controlled Trial
title_short Analysis of Usage Data from a Self-Guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Controlled Trial
title_sort analysis of usage data from a self-guided app-based virtual reality cognitive behavior therapy for acrophobia: a randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357041/
https://www.ncbi.nlm.nih.gov/pubmed/32466528
http://dx.doi.org/10.3390/jcm9061614
work_keys_str_mv AT donkertara analysisofusagedatafromaselfguidedappbasedvirtualrealitycognitivebehaviortherapyforacrophobiaarandomizedcontrolledtrial
AT vanklaverenchris analysisofusagedatafromaselfguidedappbasedvirtualrealitycognitivebehaviortherapyforacrophobiaarandomizedcontrolledtrial
AT corneliszilja analysisofusagedatafromaselfguidedappbasedvirtualrealitycognitivebehaviortherapyforacrophobiaarandomizedcontrolledtrial
AT kokrobinn analysisofusagedatafromaselfguidedappbasedvirtualrealitycognitivebehaviortherapyforacrophobiaarandomizedcontrolledtrial
AT vangelderjeanlouis analysisofusagedatafromaselfguidedappbasedvirtualrealitycognitivebehaviortherapyforacrophobiaarandomizedcontrolledtrial